Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01829659 · ClinicalTrials.gov registry record
The ACS Ethnicity Platelet Function Study
A clinical trial, sponsored by Medstar Health Research Institute.
- Completed
- Registry status
- 4
- Enrollment target
NCT01829659 is a clinical trial that has completed, run by Medstar Health Research Institute. The registered enrollment target is 4 participants.
The verdict
NCT01829659 has completed, sponsored by Medstar Health Research Institute.
- COMPLETED
- Registry status
- 4 participants
- Enrollment target
Study Summary
This study is being done to assess the effects of the CTP inhibitor on the function of your platelets (cells within your blood that are involved in the formation of blood clots) and to assess whether you have responded to the ticagrelor well enough to prevent the formation of blood clots within the stent or site in which angioplasty was performed. Recent studies have looked at how racial differences can affect platelet reactivity, the way blood clots. But these studies have not looked at the way different racial backgrounds can affect the way the blood forms clots. Minorities, such as African-Americans are underrepresented. Therefore, we are conducting this platelet reactivity study to better understand if there are differences in how this drug affects African-Americans from how they affect Caucasian patients undergoing percutaneous coronary intervention and receiving ticagrelor. These data will be compared to a historical control of Caucasian patients who underwent similar platelet function testing.
Interventions
- DRUG Ticagrelor
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 4 participants |
| Start Date | 2013-05 |
| Est. Completion | 2016-05 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01829659
The ClinicalTrials.gov registry entry for NCT01829659 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 4 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Medstar Health Research Institute, which has 115 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Ticagrelor is the first listed.
NCT01829659 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01829659 about?
NCT01829659 is a clinical study titled "The ACS Ethnicity Platelet Function Study". This study is being done to assess the effects of the CTP inhibitor on the function of your platelets (cells within your blood that are involved in the formation of blood clots) and to assess whether you have responded to the ticagrelor well enough to prevent the formation of blood clots within the ...
What is the current status of trial NCT01829659?
This trial is currently completed. The enrollment target is 4 participants. The study started on 2013-05. Estimated completion is 2016-05.
What interventions are being tested in trial NCT01829659?
The interventions under investigation include: Ticagrelor (DRUG).
Who is sponsoring clinical trial NCT01829659?
This trial is sponsored by Medstar Health Research Institute, which has 115 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.